Pharmaceutical Outcomes & Policy Innovations

The Pharmaceutical Outcomes & Policy Innovations (POPi) unit conducts research to inform and improve pharmaceutical policy, with nearly three decades of work translating evidence into better care.

Welcome to POPi

Innovative Research. Innovative Care.

For almost 30 years the POPi research unit has fostered pharmaceutical policy innovation through proactive research and knowledge translation. Welcome to our site, where you’ll learn more about our team and our work!

Innovative Research Leading to Optimal Outcomes

Learn More About POPi: Advancing Pediatric Medication Safety

Since 1991, the Pharmaceutical Outcomes & Policy Innovations (POPi) program has worked to improve the safety and cost-effectiveness of medication use in children.

About Our Research Capabilities

POPi’s research spans drug effectiveness and drug safety, supported by resources like the Genomic and Outcomes Databank for Pharmacogenomic and Implementation Studies (GO PGx). Below, explore selected research studies and our work integrating pediatric pharmacogenomic testing into the Canadian health care system.

Research Capabilities

Publications

Explore a list of POPi’s published research contributing to the field of pediatric medication safety and pharmacogenomics.

Contact Us

Have questions or want to get in touch? Contact us!

Contact

Links

Check out our resources.

Links